This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2008 Mar;5(3):132-3.

doi: 10.1038/ncponc1044.

Does combining docetaxel with cisplatin and fluorouracil improve clinical benefit in advanced gastroesophageal cancer?

Gihan Ratnayake¹, David Cunningham

Affiliations

PMID: 18253105
DOI: 10.1038/ncponc1044

Comment

Does combining docetaxel with cisplatin and fluorouracil improve clinical benefit in advanced gastroesophageal cancer?

Gihan Ratnayake et al. Nat Clin Pract Oncol. 2008 Mar.

. 2008 Mar;5(3):132-3.

doi: 10.1038/ncponc1044.

Authors

Gihan Ratnayake¹, David Cunningham

Affiliation

¹ Lymphoma and Gastrointestinal Unit, Royal Marsden Hospital, Sutton, UK.

PMID: 18253105
DOI: 10.1038/ncponc1044

No abstract available

PubMed Disclaimer

Comment on

Clinical benefit with docetaxel plus fluorouracil and cisplatin compared with cisplatin and fluorouracil in a phase III trial of advanced gastric or gastroesophageal cancer adenocarcinoma: the V-325 Study Group.
Ajani JA, Moiseyenko VM, Tjulandin S, Majlis A, Constenla M, Boni C, Rodrigues A, Fodor M, Chao Y, Voznyi E, Marabotti C, Van Cutsem E; V-325 Study Group. Ajani JA, et al. J Clin Oncol. 2007 Aug 1;25(22):3205-9. doi: 10.1200/JCO.2006.10.4968. J Clin Oncol. 2007. PMID: 17664467 Clinical Trial.

Publication types

Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.